Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAIn this issue of JAMA Psychiatry, in a cohort study drawn from the Danish population registry, Steinberg et al concluded that neither medication abortion nor procedural abortion was associated with a statistically significant increase in the risk for psychotropic medication use after adjustment for multiple testing. They estimated the risk of mild mental health symptoms before and after abortion by considering filled psychotropic medication prescriptions before and after a first-time, first-trimester abortion, according to whether the method was pharmacologic or procedural. Each patient served as a self-matched control by comparing the incidence rates of mild mental health problems in the periods immediately before (1 year) and in several periods after (≤1 year, >1 to 2 years, >2 to 5 years, and >5 years) the abortion. In Denmark, psychotropic medication prescriptions by general practitioners usually indicate less severe mental health problems than those diagnosed and treated by mental health specialists, hence the description as mild. This investigation follows the authors’ previous publication using the same data source and study design, which indicated that neither medication abortion nor procedural abortion increased the risks for any first-time psychiatric diagnosis, mood disorder diagnosis, or anxiety or stress disorder diagnosis.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Medication and Procedural Abortion and Risk of Psychotropic Medication Use | 0 | 6.88 | 01-10-2026 |
| 2 | Depression and SSRI Treatment During Pregnancy | 0 | 8.77 | 01-10-2026 |
| 3 | Blinding Integrity and Psychedelic Drug Trials | 0 | 12.75 | 01-10-2026 |
| 4 | JAMA Psychiatry | 0 | 5.97 | 01-10-2026 |
| 5 | Blinding Integrity and Psychedelic Drug Trials | 0 | 17.3 | 01-10-2026 |
| 6 | expert reaction to a population cohort study on prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes | 0 | 8.32 | 29-09-2026 |
| 7 | Blinding Integrity and Psychedelic Drug Trials—Reply | 0 | 7.17 | 01-10-2026 |
| 8 | Fabomotizole corrects behavioral impairments in a postnatal propionic acid model of autism spectrum disorders in rats | 0 | 3.84 | 29-06-2026 |
| 9 | Could a Ketogenic Diet Improve Psychiatric Symptoms? A Randomized Controlled Trial | 0 | 5.16 | 25-08-2026 |
| 10 | When a Psychiatric Diagnosis Doesn’t Tell the Whole Story | 0 | 8.09 | 25-09-2026 |